Translumina is an innovative cardiovascular medical device company specializing in advanced solutions for interventional cardiology and vascular procedures. Its product portfolio includes drug eluting stents, drug coated balloons, coronary balloons and other cardiovascular and vascular intervention devices. The company focuses on combining innovative technology with clinical expertise, rigorous quality standards and advanced manufacturing capabilities to develop reliable medical devices for healthcare professionals. Translumina supports the evolving needs of cardiovascular intervention through continuous research and development, clinical evaluation and regulatory expertise.